These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15332217)

  • 1. Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease.
    Gadegbeku CA; Shrayyef MZ; LaPorte FB; Egan BM
    Am J Kidney Dis; 2004 Sep; 44(3):446-54. PubMed ID: 15332217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension.
    Gadegbeku CA; Shrayyef MZ; Taylor TP; Egan BM
    J Hypertens; 2006 Jul; 24(7):1383-9. PubMed ID: 16794488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity.
    Haastrup AT; Stepniakowski KT; Goodfriend TL; Egan BM
    Hypertension; 1998 Oct; 32(4):693-8. PubMed ID: 9774365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raising lipids acutely reduces baroreflex sensitivity.
    Gadegbeku CA; Dhandayuthapani A; Sadler ZE; Egan BM
    Am J Hypertens; 2002 Jun; 15(6):479-85. PubMed ID: 12074347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
    Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
    Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.
    Gadegbeku CA; Dhandayuthapani A; Taylor TP; Shrayyef Z; Gerich J; Garvey WT; Egan BM
    J Am Soc Hypertens; 2007; 1(6):414-22. PubMed ID: 20409874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of chronic kidney disease in Chinese hospitalized adult patients: investigation of 13,383 cases].
    Wu XC; Liu BC; Wang YL; Wang B; Gao J; Zhang QJ; Zhu Y; Zhang XL; Yin LF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2672-6. PubMed ID: 18167241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure responses to phenylephrine infusions in subjects with Cushing's syndrome.
    McKnight JA; Rooney DP; Whitehead H; Atkinson AB
    J Hum Hypertens; 1995 Oct; 9(10):855-8. PubMed ID: 8576903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and postprandial triglyceride levels in primary renal disease.
    Charlesworth JA; Kriketos AD; Jones JE; Erlich JH; Campbell LV; Peake PW
    Metabolism; 2005 Jun; 54(6):821-8. PubMed ID: 15931621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC; Tsai WC; Chen JY; Huang JJ
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased vascular alpha1-adrenergic sensitivity in patients with renal failure: receiving recombinant erythropoeitin.
    Abiose AK; Aronow WS; Moreno H; Nair CK; Blaschke TF; Hoffman BB
    Am J Ther; 2007; 14(5):427-34. PubMed ID: 17890929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
    Tokmakova MP; Skali H; Kenchaiah S; Braunwald E; Rouleau JL; Packer M; Chertow GM; Moyé LA; Pfeffer MA; Solomon SD
    Circulation; 2004 Dec; 110(24):3667-73. PubMed ID: 15569840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of fatty acids induced suppression of cardiovascular reflexes in rats.
    Shaltout HA; Abdel-Rahman AA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1328-37. PubMed ID: 15937146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysomnographic measures of nocturnal sleep in patients on chronic, intermittent daytime haemodialysis vs those with chronic kidney disease.
    Parker KP; Bliwise DL; Bailey JL; Rye DB
    Nephrol Dial Transplant; 2005 Jul; 20(7):1422-8. PubMed ID: 15840682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.